tailieunhanh - From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery - a case report

Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is associated with poorer response to chemotherapy and chemoradiotherapy. The role of the combination of metronomic capecitabine and bevacizumab in patients with MAC merits further investigation. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN